Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3 [Phase 3]

View source ↗

Summary

Status update on a Phase 3 trial evaluating the efficacy and safety of venglustat for Gaucher disease type 3; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gaucher Disease Type

Drugs mentioned

• Venglustat (venglustat)

Snippet

Sponsor: Sanofi | Conditions: Gaucher's Disease Type III | Phase 3 | Status: ACTIVE_NOT_RECRUITING